Notes
National Health Service
Reference
NICE. Long term benefit of neuroblastoma treatment is too uncertain, says NICE. Internet Document : 4 May 2018. Available from: URL: https://www.nice.org.uk/news/article/long-term-benefit-of-neuroblastoma-treatment-is-too-uncertain-says-nice
Rights and permissions
About this article
Cite this article
Dinutuximab beta not recommended by NICE. PharmacoEcon Outcomes News 803, 32 (2018). https://doi.org/10.1007/s40274-018-4959-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4959-2